logo
Plus   Neg
Share
Email

Aphria Completes First Shipment Of Dried Flower To Germany

Canadian cannabis company Aphria Inc. said it has completed its first shipment of dried cannabis flower from its facility in Canada to Germany. The company noted that the shipment strengthens its position as a leading cannabis company in Germany and the European Union.

Aphria said that the first shipment of dried flower to its wholly-owned German subsidiary, CC Pharma GmbH, was completed from its Aphria One facility in Ontario, which is certified for European Union-Good Manufacturing Practices or EU GMP.

CC Pharma is a distributor of pharmaceutical products to more than 13,000 pharmacies in Germany.

"We are leveraging our strong medical platform and multi-faceted German strategy, which combines domestic cultivation, import licenses and large distribution infrastructure, to increase access to high-quality medical cannabis for patients worldwide. We remain excited about future milestones, including the completion of our cultivation facility in Neumünster, Germany, which we expect will be completed in Q2 FY2021," said Irwin Simon, Chief Executive Officer of Aphria.

The German market is considered to be one of the most highly sought-after developed medical cannabis markets in the world.

Aphria said its German operations were preparing for the import of EU-GMP certified cannabis from Canada, allowing for shipments to CC Pharma in order to leverage CC Pharma's expansive in-country distribution network.

Aphria said it launched several CBD-based wellness brands in Germany in the first quarter of 2021.

These include CannRelief brand, a line of cosmetic oils and creams as well as supplements; Evoque brand, which includes skin products such as face creams and serums; and CannaPet brand, a line of products that bring relaxation, relief or recovery to pets.

The German market is the largest and fastest growing market for medical cannabis in Europe.

According to the Medical Cannabis Network, the medical cannabis market in Germany is currently valued at between 150 million euros and 175 million euros, despite only around 10 percent of the 20,000 pharmacies in Germany currently selling medical cannabis products.

Earlier this week, MediPharm Labs Corp. said that German pharmaceutical company STADA Arzneimittel AG signed an exclusive medical cannabis supply agreement with MediPharm's wholly owned subsidiary. Canada-based MediPharm Labs is a provider of cannabis oil and concentrates.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The United Kingdom's Competition and Markets Authority (CMA) has launched an investigation into technology giant Apple Inc. (AAPL) following complaints that its terms and conditions for app developers are unfair and anti-competitive. iPhone maker Apple also operates the App Store, which is the only... Supermarket chain Kroger Co. on Thursday reported that it posted a loss for the fourth quarter compared to a profit last year, hurt by pension plan withdrawal liabilities. Adjusted earnings per share topped analysts' estimates, while quarterly revenues missed it. However, the company initiated adjusted earning guidance for the full-year 2021, well above analysts' estimates. Retail sales are projected to grow at a potentially record rate during 2021, but the ongoing COVID-19 pandemic remains the biggest challenge for the year, according to the National Retail Federation. "There is no doubt the economy is positioned for growth in 2021, but how much growth comes down to a single non-economic force - the coronavirus," NRF Chief Economist Jack Kleinhenz said.
Follow RTT